CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a new tool for detecting and monitoring metastatic cancer through acoustic whole-blood cytometry. By enabling the enumeration of circulating tumor cells with minimal pre-treatment, the project seeks to improve treatment prediction and monitoring for breast and prostate cancer patients.
This project addresses the need for new tools to detect and monitor the disease progression in patients with metastatic cancer.
Breast and prostate cancer are the most common malignant cancers in women and men, respectively.
Metastasis is the main threat in these cancers since it turns a curable local disease into a chronic lethal disease.
With emerging new targeting therapies, there is an unmet clinical need for improved prognostication, treatment prediction and treatment monitoring, where circ…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
